Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Cat litter is a possible trigger for sarcoidosis

M. Drent, P.A. Wijnen, A.W. Boots, A. Bast
European Respiratory Journal 2012 39: 221-222; DOI: 10.1183/09031936.00074411
M. Drent
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ildcare@gmail.com
P.A. Wijnen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.W. Boots
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Bast
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editors:

Sarcoidosis is characterised by cellular immune activity with noncaseating granuloma formation in various organ systems with a multifactorial cause. Many causative agents are considered to be involved in the pathogenesis [1–5]. Gene–environment interactions offer the potential for strengthening the evidence of causation between exposures and sarcoidosis. It is important to identify every potential exposure to triggers in order to avoid irreversible damage. Inorganic agents, including silica, have been reported to initiate inflammation and granulomatous reactions [6, 7]. It is well known that cats can cause allergic reactions, but less is known about the association of inflammation and cat litter. We propose that silica, the major component of cat litter, might be such an agent. We report a case of biopsy-proven sarcoidosis with birefringent material, mainly silica, within the lung biopsy specimen. The patient had no relevant occupational history, but had cats and was extensively exposed to silica-containing cat litter. Initially, the patient improved after starting immunosuppressive drugs and terminating contact with litter. However, she deteriorated twice after autoprovocation (re-exposure) to cat litter. After changing the silica-containing cat litter for litter without silica, her clinical condition improved substantially. Obviously, she appeared to be “hypersensitive” not to the cats but to the cat litter.

A 44-yr-old female was admitted to the former ILD Care Team (a tertiary referral centre) of the Dept of Respiratory Medicine, Maastricht University Medical Centre (Maastricht, the Netherlands). The patient had been diagnosed with sarcoidosis 4 yrs prior to admission. She had no medical history and did not smoke or use any medication. The diffusing capacity of the lung for carbon monoxide was impaired (62% predicted). A chest radiograph demonstrated a micronodular interstitial pattern without enlargement of lymph nodes (stage III), and was confirmed by a high-resolution computed tomography (CT) scan. Inflammatory signs of sarcoidosis were increased, including angiotensin-converting enzyme (ACE) (30 U·L−1, normal range 9–25 U·L−1) and soluble interleukin-2 receptor (sIL-2R) (4,518 pg·mL−1, reference range 240–3,154 pg·mL−1), and a whole-body 18F-2-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET)/CT scan demonstrated uptake in the lung parenchyma and spleen indicative of sarcoidosis inflammatory activity. Bronchoalveolar lavage fluid analysis revealed a cellular pattern compatible with sarcoidosis (a lymphocytosis of 26%) [8]. A lung biopsy showed granulomas consistent with sarcoidosis with birefringent material. A detailed history excluded occupational or environmental exposure to silica. However, she had eight cats and four of them were sleeping in two cat boxes in her bedroom. Treatment with prednisone was started. As her clinical situation did not improve after 2 months, methotrexate (MTX) (12.5 mg once a week orally with 5 mg folic acid once a week, taken on a different day to the MTX) was added. We also advised her to temporarily avoid any contact with the cats, especially the cat litter.

The patient’s clinical condition improved dramatically within 6 months, and we were able to taper off the prednisone and finally stop the MTX after 1 yr of treatment. At that time, ACE (20 U·L−1) and sIL-2R (2,361 pg·L−1) were within normal limits. Moreover, a control PET/CT scan was negative. As she felt much better, she decided to take back her cats and 2 months later, her clinical situation deteriorated and all earlier signs of sarcoidosis activity returned. Since she adored her cats so much, we advised her to search for silica-free cat litter. She found a cat litter made out of old newspapers, without silica and that was not dusty. Shortly after starting to use this, she felt much better. She was stable for almost 2 yrs without any sign of inflammation associated with sarcoidosis. Thereafter, she visited her son for 3 weeks. He has three cats and the “wrong” cat litter. 1 month later, she deteriorated again and blamed herself for not having the foresight to ask him to replace his cat litter with her own (nonsilica) brand.

Sarcoidosis susceptibility depends on both environmental and genetic modifiers [1, 4, 5]. Inflammation in sarcoidosis is characterised by ongoing T-cell and macrophage activity and granuloma formation reflected by an increase of serological markers of inflammation or abnormality in glucose metabolism demonstrated as high uptake on 18F-FDG PET/CT [4, 9]. Moreover, the endogenous antioxidant defence was found to be significantly reduced in sarcoidosis, indicating that oxidative stress underlies the pathology of this disease [10, 11]. Silica granulomatosis is a delayed hypersensitivity response to crystalline silica. The biological plausibility of a relationship between exposure to silica and autoimmune and inflammatory disorders has already been proposed [1–3]. Recently, Solà et al. [6] reported a very interesting case suggesting a new association between ingestion of anhydrous colloidal silica (a vehicle for some oral drug formulations) and sarcoidosis. In our case, the suggestion is that the response to silica, a component of the cat litter, is probably the end result of an immune and inflammatory response in a genetically susceptible host [6]. Similar reactions related to exposure to talc, a group of hydrous magnesium silicates, have been reported [12].

The clinical condition improved within 6 months after withdrawal of the silica-containing cat litter. However, the patient deteriorated twice after autoprovocation by the return of the cats and litter boxes. This temporary clinical improvement strongly implicates silica as the cause of the patient’s sarcoidosis, since the symptoms were induced after exposure to the cat litter containing crystalline silica and disappeared when exposure was terminated. Energy-dispersive X-ray spectrum analysis of small samples of the cat litter showed peaks of mainly silica (fig. 1).

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

Energy-dispersive X-ray spectrum analysis of cat litter used by the presented patient with peaks of silica (1.740 keV) and aluminium (1.486 keV) particularly evident. The peaks for sulfur, chlorine, potassium, titanium, iron and copper originate from the supporting material.

This admittedly exceptional case shows that caution should always be exercised when making a diagnosis of sarcoidosis and that recreational, as well as occupational and environmental exposures, must be considered. Furthermore, it underlines the extreme importance of a thorough exposure history. It would be very challenging to explore whether this observation is only anecdotal or could be an explanation for the development of similar “sarcoid-like” reactions in more cases. Although crystalline silica exposure has been known to be associated with sarcoidosis, the present case provides evidence of an unexpected association between the substantial exposure to silica-containing cat litter and sarcoidosis or a “sarcoid-like” granulomatous reaction. Obviously, this is important, as many people have cats with litter boxes. Therefore, it was recommended not to get rid of the cats but rather choose appropriate cat litter, without silica. This case stresses: “if you are not aware of it, you will not recognise it!”

Acknowledgments

The authors acknowledge P.H.H. Bomans (Technical University Eindhoven, Eindhoven, the Netherlands) for performing the electron microscopy analysis.

Footnotes

  • Statement of Interest

    None declared.

  • ©ERS 2012

REFERENCES

  1. ↵
    1. Culver DA,
    2. Newman LS,
    3. Kavuru MS
    . Gene–environment interactions in sarcoidosis: challenge and opportunity. Clin Dermatol 2007; 25: 267–275.
    OpenUrlCrossRefPubMedWeb of Science
    1. Drent M,
    2. Bomans PH,
    3. Van Suylen RJ,
    4. et al
    . Association of man-made mineral fibre exposure and sarcoidlike granulomas. Respir Med 2000; 94: 815–820.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Rafnsson V,
    2. Ingimarsson O,
    3. Hjalmarsson I,
    4. et al
    . Association between exposure to crystalline silica and risk of sarcoidosis. Occup Environ Med 1998; 55: 657–660.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Iannuzzi MC,
    2. Rybicki BA,
    3. Teirstein AS
    . Sarcoidosis. N Engl J Med 2007; 357: 2153–2165.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Nathan C
    . Points of control in inflammation. Nature 2002; 420: 846–852.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Solà R,
    2. Boj M,
    3. Hernandez-Flix S,
    4. et al
    . Silica in oral drugs as a possible sarcoidosis-inducing antigen. Lancet 2009; 373: 1943–1944.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Calvert GM,
    2. Rice FL,
    3. Boiano JM,
    4. et al
    . Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 2003; 60: 122–129.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Drent M,
    2. Jacobs JA,
    3. Cobben NA,
    4. et al
    . Computer program supporting the diagnostic accuracy of cellular BALF analysis: a new release. Respir Med 2001; 95: 781–786.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Keijsers RG,
    2. Verzijlbergen JF,
    3. van Diepen DM,
    4. et al
    . 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25: 143–149.
    OpenUrlPubMedWeb of Science
  9. ↵
    1. Koutsokera A,
    2. Papaioannou AI,
    3. Malli F,
    4. et al
    . Systemic oxidative stress in patients with pulmonary sarcoidosis. Pulm Pharmacol Ther 2009; 22: 603–607.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Drent M,
    2. van den Berg R,
    3. Haenen GR,
    4. et al
    . NF-κB activation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 50–56.
    OpenUrlPubMedWeb of Science
  11. ↵
    1. Iqbal A,
    2. Aggarwal B,
    3. Menon B,
    4. et al
    . Talc granulomatosis mimicking sarcoidosis. Singapore Med J 2008; 49: e168–e170.
    OpenUrlPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 39 Issue 1 Table of Contents
European Respiratory Journal: 39 (1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cat litter is a possible trigger for sarcoidosis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Cat litter is a possible trigger for sarcoidosis
M. Drent, P.A. Wijnen, A.W. Boots, A. Bast
European Respiratory Journal Jan 2012, 39 (1) 221-222; DOI: 10.1183/09031936.00074411

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Cat litter is a possible trigger for sarcoidosis
M. Drent, P.A. Wijnen, A.W. Boots, A. Bast
European Respiratory Journal Jan 2012, 39 (1) 221-222; DOI: 10.1183/09031936.00074411
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Burden of CAP in Italian general practice
  • Neutrophilia independently predicts death in tuberculosis
  • Fibrosis in dyskeratosis congenita with TINF2 mutation
Show more Letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society